Clínic Barcelona

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs selected in accordance with their PD-1 protein expression levels.

From lesft to right: Tomás Pascual, Azucena González, Manel Juan, Eulalia Olesti, Mariona Pascal y Aleix Prat (Foto: Francisco Avia)

Related contents
Keep reading about: